Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Malaria | Opinion

Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic

Authors: Prasad Ranaweera, Rajitha Wickremasinghe, Kamini Mendis

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

The COVID-19 pandemic has had a considerable impact on other health programmes in countries, including on malaria, and is currently under much discussion. As many countries are accelerating efforts to eliminate malaria or to prevent the re-establishment of malaria from recently eliminated countries, the COVID-19 pandemic has the potential to cause major interruptions to ongoing anti-malaria operations and risk jeopardizing the gains that have been made so far. Sri Lanka, having eliminated malaria in 2012, was certified by the World Health Organization as a malaria-free country in 2016 and now implements a rigorous programme to prevent its re-establishment owing to the high receptivity and vulnerability of the country to malaria. Sri Lanka has also dealt with the COVID-19 epidemic quite successfully limiting the cumulative number of infections and deaths through co-ordinated efforts between the health sector and other relevant sectors, namely the military, the Police Department, Departments of Airport and Aviation and Foreign Affairs, all of which have been deployed for the COVID-19 epidemic under the umbrella of a Presidential Task Force. The relevance of imported infections and the need for a multi-sectoral response are features common to both the control of the COVID-19 epidemic and the Prevention of Re-establishment (POR) programme for malaria. Sri Lanka’s malaria POR programme has, therefore, creatively integrated its activities with those of the COVID-19 control programme. Through highly coordinated operations the return to the country of Sri Lankan nationals stranded overseas by the COVID-19 pandemic, many from malaria endemic countries, are being monitored for malaria as well as COVID-19 in an integrated case surveillance system under quarantine conditions, to the success of both programmes. Twenty-three imported malaria cases were detected from February to October through 2773 microscopic blood examinations performed for malaria in quarantine centres, this number being not much different to the incidence of imported malaria during the same period last year. This experience highlights the importance of integrated case surveillance and the need for a highly coordinated multi-sectoral approach in dealing with emerging new infections. It also suggests that synergies between the COVID-19 epidemic control programme and other health programmes may be found and developed to the advantage of both.
Literature
2.
go back to reference The Global Fund. Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malaria. 2020. The Global Fund. Mitigating the impact of COVID-19 on countries affected by HIV, tuberculosis and malaria. 2020.
4.
go back to reference Dharmawardena P, Premaratne R, Gunasekera W, Hewawitarane M, Mendis K, Fernando D. Characterization of imported malaria, the largest threat to sustained malaria elimination from Sri Lanka. Malar J. 2015;14:177. CrossRefPubMedCentralPubMed Dharmawardena P, Premaratne R, Gunasekera W, Hewawitarane M, Mendis K, Fernando D. Characterization of imported malaria, the largest threat to sustained malaria elimination from Sri Lanka. Malar J. 2015;14:177. CrossRefPubMedCentralPubMed
5.
go back to reference Mendis K. Eliminating malaria should not be the end of vigilance. Nat World View. 2019;573:7. Mendis K. Eliminating malaria should not be the end of vigilance. Nat World View. 2019;573:7.
6.
go back to reference Karunasena VM, Marasinghe M, Amarasinghe S, Koo C, Senaratne PAS, Hasantha MBR, et al. The first introduced malaria case reported from Sri Lanka after elimination: implications for preventing the re-introduction of malaria in recently eliminated countries. Malar J. 2019;18:210. CrossRefPubMedCentralPubMed Karunasena VM, Marasinghe M, Amarasinghe S, Koo C, Senaratne PAS, Hasantha MBR, et al. The first introduced malaria case reported from Sri Lanka after elimination: implications for preventing the re-introduction of malaria in recently eliminated countries. Malar J. 2019;18:210. CrossRefPubMedCentralPubMed
8.
go back to reference Fernando S, Dharmawardana P, Semege S, Epasinghe G, Senanayake N, Rodrigo C, et al. The risk of imported malaria in security forces personnel returning from overseas missions in the context of prevention of re-introduction of malaria to Sri Lanka. Malar J. 2016;15:144. CrossRefPubMedCentralPubMed Fernando S, Dharmawardana P, Semege S, Epasinghe G, Senanayake N, Rodrigo C, et al. The risk of imported malaria in security forces personnel returning from overseas missions in the context of prevention of re-introduction of malaria to Sri Lanka. Malar J. 2016;15:144. CrossRefPubMedCentralPubMed
9.
go back to reference Fernando SD, Booso R, Dharmawardena P, Harintheran AA, Raviraj K, Rodrigo C, et al. The need for preventive and curative services for malaria when military is deployed in endemic overseas territories: a case study and lessons learnt. Mil Med Res. 2017;4:19. PubMedPubMedCentral Fernando SD, Booso R, Dharmawardena P, Harintheran AA, Raviraj K, Rodrigo C, et al. The need for preventive and curative services for malaria when military is deployed in endemic overseas territories: a case study and lessons learnt. Mil Med Res. 2017;4:19. PubMedPubMedCentral
Metadata
Title
Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic
Authors
Prasad Ranaweera
Rajitha Wickremasinghe
Kamini Mendis
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Malaria
COVID-19
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03465-5

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.